ISRG
MX$10,893.00
▼-0.17%
Stock
Intuitive Surgical, Inc.
Official Company Name: Intuitive Surgical, Inc.
Stock Symbol: ISRG
Stock Market: Mexican Stock Exchange - BMV
Currency: Mexican peso - MXN
ISRG Stock Price - 1 Year Price Evolution & Moving Averages
1 Year Return
▲+67.99%
Daily closing prices, with moving averages and volumes - Mexican peso (MXN)
Moving averages:
- — EMA20
- — SMA50
- — SMA200
United States
Company Description
Intuitive Surgical Inc. is a medical device company developing, manufacturing, and marketing minimally invasive surgical platforms and future diagnostic tools. Its flagship product, the da Vinci robotic-assisted system, allows surgeons to enter and explore the body through a single small incision; it was one of the first to be cleared by the American Food and Drug Administration.
ISRG Stock Data
| Open | MX$10,893.00 |
| High | MX$10,893.00 |
| Low | MX$10,893.00 |
| Close | MX$10,893.00 |
| Volume | 15 |
| Previous Close | MX$10,911.19 |
| 1-Day Change | -18.19 |
| 1-Year Change | 4408.87 |
| Average Daily Volume | 241 |
| 52-Week High | MX$12,500.37 |
| 52-Week Low | MX$6,484.13 |
Ratios as of Jan. 25, 2025
| Beta | 1.39 |
| Trailing PE | 95.25 |
| Forward PE | 77.44 |
Disclaimer
All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!
Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.
Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).
Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.
Please conduct your own due diligence to verify insights.